A CRIMEAN-CONGO HAEMORRHAGIC FEVER OUTBREAK IN NORTHERN BALOCHISTAN

被引:0
|
作者
Ali, Nadir [1 ]
Chotani, Rashid A. [2 ,3 ,4 ]
Anwar, Masood [5 ]
Nadeem, Mansoor [1 ]
Karamat, Karamat Ahmed [6 ]
Tariq, Waheed Uz Zaman [5 ]
机构
[1] CMH, Dept Pathol, Karachi, Pakistan
[2] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
[3] Johns Hopkins Bloomburg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[4] Johns Hopkins Sch Med & Publ Hlth, Baltimore, MD USA
[5] Army Med Coll, Dept Pathol, Rawalpindi, Pakistan
[6] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan
关键词
Crimean-Congo hemorrhagic fever (CCHF); Endemic; Anti-viral; Oral Ribavirin; Clinical management; Gastrointestinal hemorrhage;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To describe the clinical characteristics, epidemiology, predictors of fatal outcome (PFO), and management effects of Crimean-Congo haemorrhagic fever (CCHF) patients during an outbreak in Northern Balochistan. Design: Descriptive study. Place and Duration of Study: Fatima Jinnah Hospital and Combined Military Hospital, Quetta, from June to October, 2001. Patients and Methods: Patients presenting with a fever of less than 2 weeks duration and bleeding manifestations were included. Clinical history was recorded and patients were placed on oral ribavirin, and hematological support. Diagnosis was established by PCR for CCHF or detection of CCHF specific IgM and IgG. Results: Eighty-four patients were received, 34 (40.5%) were suspected of suffering from classical CCHF. All 34 (100%) patients presented with a history of fever and bleeding (epistaxis, gum bleeding, melena or haematuria). Mean platelet count was 30 x 10(9)/L and mean ALT (alanine transferase) was 288 U/L. Among fatal cases, the mean platelet count was 18.4 x 10(9)/L and ALT was 781 units/L. PCR for CCHF viral RNA performed on 10 patients was positive in 3 (30%) patients. CCHF specific IgM and IgG was positive in 17.6% (6/34). Four patients were brought in moribund condition and expired before treatment could be started, 4 patients expired during treatment and 76.5% (26/34) were cured. The overall mortality was 23.5% (8/34). Main predictors of fatal outcome were ALT >= 150 units/L, activated partial thromboplastin time(aPT) >= 60 seconds, prothrombin time (PT) >= 34 seconds, aspartate transferase (AST) >= 200 units/L, platelets <= 20 x 10(9)/L, and fibrinogen <= 110 mg/dL. Conclusion: In this series of CCHF occurring in Northern parts of Balochistan, gastrointestinal tract bleeding was the worst prognostic factor associated with fatal outcome. Providing education to healthcare workers and at risk populations, hematological support, anti-viral drugs, and barrier nursing may help reduce mortality.
引用
收藏
页码:477 / 481
页数:5
相关论文
共 50 条
  • [1] Outbreak of crimean-congo haemorrhagic fever in Pakistan
    Ahmad, K
    [J]. LANCET, 2000, 356 (9237): : 1254 - 1254
  • [2] Crimean-Congo haemorrhagic fever: An outbreak in India
    Verma, Ramesh
    Khanna, Pardeep
    Prinja, Shankar
    Rajput, Meena
    [J]. AUSTRALASIAN MEDICAL JOURNAL, 2011, 4 (11): : 589 - 591
  • [3] Crimean-Congo haemorrhagic fever
    Ergönül, Ö
    [J]. LANCET INFECTIOUS DISEASES, 2006, 6 (04): : 203 - 214
  • [4] Crimean-Congo haemorrhagic fever
    Peyrefitte, C.
    Marianneau, P.
    Tordo, N.
    Bouloy, M.
    [J]. REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES, 2015, 34 (02): : 391 - 401
  • [5] SHORT REPORT Nosocomial outbreak of Crimean-Congo haemorrhagic fever
    Naderi, H. R.
    Sarvghad, M. R.
    Bojdy, A.
    Hadizadeh, M. R.
    Sadeghi, R.
    Sheybani, F.
    [J]. EPIDEMIOLOGY AND INFECTION, 2011, 139 (06): : 862 - 866
  • [6] Large outbreak of Crimean-Congo haemorrhagic fever in Iraq, 2022
    Alhilfi, Riyadh Abdulameer
    Khaleel, Hanan Abdulghafoor
    Raheem, Baghdad Muayad
    Mahdi, Sinan Ghazi
    Tabche, Celine
    Rawaf, Salman
    [J]. IJID REGIONS, 2023, 6 : 76 - 79
  • [7] Crimean-Congo haemorrhagic fever in Mali
    Zwizwai, Ruth
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (03): : 293 - 293
  • [8] Crimean-Congo haemorrhagic fever in Oman
    Scrimgeour, EM
    Zaki, A
    Mehta, FR
    Abraham, AK
    AlBusaidy, S
    ElKhatim, H
    AlRawas, SFS
    Kamal, AM
    Mohammed, AJ
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1996, 90 (03) : 290 - 291
  • [9] Crimean-Congo haemorrhagic fever in Eurasia
    Leblebicioglu, Hakan
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 : S43 - S46
  • [10] Crimean-Congo haemorrhagic fever in Oman
    Scrimgeour, EM
    [J]. LANCET, 1996, 347 (9002): : 692 - 692